3 completed, 1 recruiting, 1 unknown. 4 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Drug Kinetics: new trials by email Literature Review of Drug Kinetics trials Research Report on Drug Kinetics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opioid Drug Interaction Study Alprazolam, Oxycodone, Placebo - Drug Interactions, Drug Kinetics | Phase 1 / Phase 2 | Recruiting | Shanna Babalonis, PhD | 25 | 2025-04-01 | 2026-05-14 |
| Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib Radotinib HCl - Drug Kinetics | Phase 1 | Completed | Il-Yang Pharm. Co., Ltd. | 24 | 2024-07-22 | 2025-04-30 |
| Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation sargramostim - Drug Kinetics, Drug Effects on Physiology | Phase 1 | Completed | Partner Therapeutics, Inc. | 42 | 2022-04-13 | 2022-10-03 |
| A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG Women Azithromycin plus piperaquine phosphate, Sulfadoxine-pyrimethamine - Pregnancy, Infections, Plasmodia | Phase 4 | Unknown | Papua New Guinea Institute of Medical Research | 150 | 2012-10-01 | 2015-10-15 |
| PET Imaging of Brain mGluR5 Receptors Using [18F]SP203 [18F]SP203 - Healthy, Glutamate Receptor | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 50 | 2007-09-28 | 2018-07-05 |
Infections (1) · Opioid-Related Disorders (1)
Chemically-Induced Disorders (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Substance-Related Disorders (1)
Alprazolam (1) · Azithromycin (1) · Colony-Stimulating Factors (1) · Oxycodone (1) · fanasil, pyrimethamine drug combination (1) · oxycodone-acetaminophen (1) · piperaquine (1) · sargramostim (1)
Il-Yang Pharm. Co., Ltd. (1) · National Institute of Mental Health (NIMH) (1) · Papua New Guinea Institute of Medical Research (1) · Partner Therapeutics, Inc. (1) · Shanna Babalonis, PhD (1)
United States (2) · Canada (1) · Papua New Guinea (1) · South Korea (1)
Ila Joshi, PhD (1) · Masahiro Fujita, M.D. (1) · Minsoo Park, PhD (1) · Shanna Babalonis, PhD (1)
R01DA016718 (1)